EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomaterial‐Based Defenders Boost Biopharmaceuticals Efficacy for Spinal Cord Injury Treatment: A Review

Xunqi Zhang, Jian Cao, Jiahe Wu, Jian‐Qing Gao

Advanced Materials Interfaces · 2023-03 · 10 (8)

DOI: 10.1002/admi.202202034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials Interfaces, online erschienen am 02.02.2023. Verfasst von Xunqi Zhang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal cord injury (SCI) has seriously affected the lives of patients and brought economic and medical burdens to society. Biopharmaceuticals, including transplanted cells, growth factors, enzyme drugs, and microRNA, present multidimensional therapeutic effects in tissue repair and regeneration, and thus are widely utilized for the treatment of SCI. Nevertheless, they still encounter great challenges. The turbulent microenvironment accompanied by various destructive components following SCI has led to poor stability, low local accumulation, and reduced therapeutic efficacy of biopharmaceuticals. To this end, biomaterial‐based defenders (BBDs) that are capable of resisting the destructive components have shown great promise in improving the survival of transplanted cells or retaining the activity of the protein and nucleic acid drugs for the treatment of SCI. In this review, various types of biopharmaceuticals applied in SCI and their limitations are introduced. The destructive components that threaten the activities of biopharmaceuticals in the rigorous microenvironment are then summarized. In particular, the current research progress about BBDs boosting the efficacy of biopharmaceuticals for the treatment of SCI is illustrated with specific examples. The existing challenges and future perspectives are also provided.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, X., Cao, J., Wu, J., & Gao, J. (2023). Biomaterial‐Based Defenders Boost Biopharmaceuticals Efficacy for Spinal Cord Injury Treatment: A Review. Advanced Materials Interfaces, 10(8). https://doi.org/10.1002/admi.202202034

Vancouver

Zhang X, Cao J, Wu J, Gao J. Biomaterial‐Based Defenders Boost Biopharmaceuticals Efficacy for Spinal Cord Injury Treatment: A Review. Advanced Materials Interfaces. 2023;10(8). doi:10.1002/admi.202202034

BibTeX
@article{Zhang2023,
  author = {Zhang, Xunqi and Cao, Jian and Wu, Jiahe and Gao, Jian‐Qing},
  title = {Biomaterial‐Based Defenders Boost Biopharmaceuticals Efficacy for Spinal Cord Injury Treatment: A Review},
  journal = {Advanced Materials Interfaces},
  year = {2023},
  volume = {10},
  number = {8},
  doi = {10.1002/admi.202202034}
}
Kostenlos starten →